Anti-Infective Agents Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030

CHAPTER 1. Industry Overview of Anti-Infective Agents Market

1.1. Definition and Scope

1.1.1. Definition of Anti-Infective Agents

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Anti-Infective Agents Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Anti-Infective Agents Market By Type

1.2.3. Anti-Infective Agents Market By Route of Administration

1.2.4. Anti-Infective Agents Market By Distribution Channel

1.2.5. Anti-Infective Agents Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Distribution Channel

2.2.1. Secondary Source

2.2.2. Primary Source

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Anti-Infective Agents Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Anti-Infective Agents Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Regulatory Compliance

3.9. Competitive Landscape, 2021

3.9.1. Player Positioning Analysis

3.9.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Anti-Infective Agents Market By Type

4.1. Introduction

4.2. Anti-Infective Agents Revenue By Type

4.2.1. Anti-Infective Agents Revenue (USD Billion) and Forecast, By Type, 2018-2030

4.2.2. Antibacterials

4.2.2.1. Antibacterials Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.2.2. Cephalosporins

4.2.2.2.1. Cephalosporins Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.2.3. Fluoroquinolones

4.2.2.3.1. Fluoroquinolones Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.2.4. Penicillin

4.2.2.4.1. Parenteral Lipid Emulsion Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.2.5. Carbapenem

4.2.2.5.1. Carbapenem Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.2.6. Macrolides

4.2.2.6.1. Macrolides Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.2.7. Others

4.2.2.7.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.3. Antivirals

4.2.3.1. Antivirals Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.3.2. Echinocandins

4.2.3.2.1. Echinocandins Lipid Emulsion Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.3.3. Azoles

4.2.3.3.1. Azoles Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.3.4. Polyenes

4.2.3.4.1. Polyenes Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.3.5. Others

4.2.3.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

4.2.4. Antifungals

4.2.4.1. Antifungals Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 5. Anti-Infective Agents Market By Route of Administration

5.1. Introduction

5.2. Anti-Infective Agents Revenue By Route of Administration

5.2.1. Anti-Infective Agents Revenue (USD Billion) and Forecast, By Route of Administration, 2018-2030

5.2.2. Topical

5.2.2.1. Topical Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.3. IV

5.2.3.1. IV Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.4. Oral

5.2.4.1. Oral Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

5.2.5. Others

5.2.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 6. Anti-Infective Agents Market By Distribution Channel

6.1. Introduction

6.2. Anti-Infective Agents Revenue By Distribution Channel

6.2.1. Anti-Infective Agents Revenue (USD Billion) and Forecast, By Distribution Channel, 2018-2030

6.2.2. Hospital Pharmacies

6.2.2.1. Hospital Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.3. E-Commerce

6.2.3.1. E-Commerce Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.4. Specialty Pharmacies

6.2.4.1. Specialty Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.5. Retail Pharmacies

6.2.5.1. Retail Pharmacies Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

6.2.6. Others

6.2.6.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2018-2030

CHAPTER 7. North America Anti-Infective Agents Market By Country 

7.1. North America Anti-Infective Agents Market Overview

7.2. U.S.

7.2.1. U.S. Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

7.2.2. U.S. Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

7.2.3. U.S. Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

7.3. Canada

7.3.1. Canada Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

7.3.2. Canada Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

7.3.3. Canada Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

7.4. North America PEST Analysis

CHAPTER 8. Europe Anti-Infective Agents Market By Country

8.1. Europe Anti-Infective Agents Market Overview

8.2. U.K.

8.2.1. U.K. Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

8.2.2. U.K. Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

8.2.3. U.K. Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

8.3. Germany

8.3.1. Germany Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

8.3.2. Germany Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

8.3.3. Germany Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

8.4. France

8.4.1. France Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

8.4.2. France Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

8.4.3. France Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

8.5. Spain

8.5.1. Spain Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

8.5.2. Spain Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

8.5.3. Spain Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

8.6. Rest of Europe

8.6.1. Rest of Europe Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

8.6.2. Rest of Europe Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

8.6.3. Rest of Europe Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

8.7. Europe PEST Analysis

CHAPTER 9. Asia Pacific Anti-Infective Agents Market By Country

9.1. Asia Pacific Anti-Infective Agents Market Overview

9.2. China

9.2.1. China Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

9.2.2. China Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

9.2.3. China Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

9.3. Japan

9.3.1. Japan Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

9.3.2. Japan Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

9.3.3. Japan Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

9.4. India

9.4.1. India Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

9.4.2. India Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

9.4.3. India Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

9.5. Australia

9.5.1. Australia Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

9.5.2. Australia Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

9.5.3. Australia Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

9.6. South Korea

9.6.1. South Korea Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

9.6.2. South Korea Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

9.6.3. South Korea Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

9.7. Rest of Asia-Pacific

9.7.1. Rest of Asia-Pacific Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

9.7.2. Rest of Asia-Pacific Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

9.7.3. Rest of Asia-Pacific Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

9.8. Asia Pacific PEST Analysis

CHAPTER 10. Latin America Anti-Infective Agents Market By Country

10.1. Latin America Anti-Infective Agents Market Overview

10.2. Brazil

10.2.1. Brazil Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

10.2.2. Brazil Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

10.2.3. Brazil Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

10.3. Mexico

10.3.1. Mexico Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

10.3.2. Mexico Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

10.3.3. Mexico Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

10.4. Rest of Latin America

10.4.1. Rest of Latin America Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

10.4.2. Rest of Latin America Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

10.4.3. Rest of Latin America Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

10.5. Latin America PEST Analysis

CHAPTER 11. Middle East & Africa Anti-Infective Agents Market By Country 

11.1. Middle East & Africa Anti-Infective Agents Market Overview

11.2. GCC

11.2.1. GCC Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

11.2.2. GCC Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

11.2.3. GCC Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.3. South Africa

11.3.1. South Africa Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

11.3.2. South Africa Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

11.3.3. South Africa Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.4. Rest of Middle East & Africa

11.4.1. Rest of Middle East & Africa Anti-Infective Agents Revenue (USD Billion) and Forecast By Type, 2018-2030

11.4.2. Rest of Middle East & Africa Anti-Infective Agents Revenue (USD Billion) and Forecast By Route of Administration, 2018-2030

11.4.3. Rest of Middle East & Africa Anti-Infective Agents Revenue (USD Billion) and Forecast By Distribution Channel, 2018-2030

11.5. Middle East & Africa PEST Analysis

CHAPTER 12. Player Analysis Of Anti-Infective Agents Market

12.1. Anti-Infective Agents Market Company Share Analysis

12.2. Competition Matrix

12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

12.2.2. New Product Launches and Product Enhancements

12.2.3. Mergers And Acquisition In Global Anti-Infective Agents Market

12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 13. Company Profile

13.1. Abbott Laboratories

13.1.1. Company Snapshot

13.1.2. Business Overview

13.1.3. Financial Overview

13.1.3.1. Revenue (USD Billion), 2021

13.1.3.2. Abbott Laboratories 2021 Anti-Infective Agents Business Regional Distribution

13.1.4. Product/Service and Specification

13.1.5. Recent Developments & Business Strategy

13.2. Astellas Pharma Inc.

13.3. Bayer AG

13.4. Bristol-Myers Squibb Company

13.5. Gilead Sciences, Inc.

13.6. GlaxoSmithKline plc.

13.7. Johnson & Johnson Services, Inc.

13.8. Merck & Co., Inc.

13.9. Novartis AG

13.10. Pfizer, Inc.

13.11. Sanofi.